Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats

Neuropsychopharmacology

Volumn 41, Issue 2, 2016, Pages 402-409

  Marchant, Nathan J ^a,b   Whitaker, Leslie R ^a   Bossert, Jennifer M ^a   Harvey, Brandon K ^a   Hope, Bruce T ^a   Kaganovsky, Konstantin ^a   Adhikary, Sweta ^a   Prisinzano, Thomas E ^c   Vardy, Eyal ^d,e   Roth, Bryan L ^e   Shaham, Yavin ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF KANSAS   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; PROTEIN FOS; SALVINORIN B; UNCLASSIFIED DRUG; CENTRAL NERVOUS SYSTEM AGENTS; COCAINE; DITERPENE; DOPAMINE UPTAKE INHIBITOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN SLICE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTROPHYSIOLOGY; FIRING RATE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LOCOMOTION; MALE; MESENCEPHALIC SLICE; MESENCEPHALON; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS SHELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBICULUM; SUBSTANTIA NIGRA; ACTION POTENTIAL; ANIMAL; CYTOLOGY; DEPENDOPARVOVIRUS; DRUG EFFECTS; FEASIBILITY STUDY; GENE TRANSFER; GENE VECTOR; GENETIC ENGINEERING; GENETICS; METABOLISM; MOTOR ACTIVITY; MUTATION; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VALIDATION STUDY;

ACTION POTENTIALS; ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; COCAINE; DEPENDOVIRUS; DITERPENES; DOPAMINE UPTAKE INHIBITORS; FEASIBILITY STUDIES; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; GENETIC VECTORS; MALE; MESENCEPHALON; MOTOR ACTIVITY; MUTATION; NEURONS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

EID: 84949623559     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.149     Document Type: Article

References (40)

1. Alexander GM, Rogan SC, Abbas AI, Armbruster BN, Pei Y, Allen JA et al (2009). Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors. Neuron 63: 27-39.
2. Ansonoff MA, Zhang J, Czyzyk T, Rothman RB, Stewart J, Xu H et al (2006). Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice. J Pharmacol Exp Ther 318: 641-648.
3. Armbruster BN, Li X, Pausch MH, Herlitze S, Roth BL (2007). Evolving the lock to fit the key to create a family of G proteincoupled receptors potently activated by an inert ligand. Proc Natl Acad Sci USA 104: 5163-5168.
4. Aschauer DF, Kreuz S, Rumpel S (2013). Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain. PLoS One 8: e76310.
5. Boender AJ, de Jong JW, Boekhoudt L, Luijendijk MC, van der Plasse G, Adan RA (2014). Combined use of the canine adenovirus-2 and DREADD-technology to activate specific neural pathways in vivo. PLoS One 9: e95392.
6. Bossert JM, Liu SY, Lu L, Shaham Y (2004). A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking. J Neurosci 24: 10726-10730.
7. Bossert JM, Poles GC, Wihbey KA, Koya E, Shaham Y (2007). Differential effects of blockade of dopamine D1-family receptors in nucleus accumbens core or shell on reinstatement of heroin seeking induced by contextual and discrete cues. J Neurosci 27: 12655-12663.
8. Bossert JM, Stern AL (2014). Role of ventral subiculum in contextinduced reinstatement of heroin seeking in rats. Addict Biol 19: 338-342.
9. Bossert JM, Stern AL, Theberge FRM, Marchant NJ, Wang HL, Morales M et al (2012). Role of projections from ventral medial prefrontal cortex to nucleus accumbens shell in context-induced reinstatement of heroin seeking. J Neurosci 32: 4982-4991.
10. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K (2005). Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 8: 1263-1268.
11. Creese I, Iversen SD (1975). The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83: 419-436.
12. Ferguson SM, Eskenazi D, Ishikawa M, Wanat MJ, Phillips PE, Dong Y et al (2011). Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization. Nat Neurosci 14: 22-24.
13. Ferguson SM, Phillips PE, Roth BL, Wess J, Neumaier JF (2013). Direct-pathway striatal neurons regulate the retention of decision-making strategies. J Neurosci 33: 11668-11676.
14. Fibiger HC, Fibiger HP, Zis AP (1973). Attenuation of amphetamine-induced motor stimulation and stereotypy by 6-hydroxydopamine in the rat. Br J Pharmacol 47: 683-692.
15. Friedman AK, Walsh JJ, Juarez B, Ku SM, Chaudhury D, Wang J et al (2014). Enhancing depression mechanisms in midbrain dopamine neurons achieves homeostatic resilience. Science 344: 313-319.
16. Grace AA (1988). In vivo and in vitro intracellular recordings from rat midbrain dopamine neurons. Ann NY Acad Sci 537: 51-76.
17. Groenewegen HJ, Vermeulen-Van der Zee E, te Kortschot A, Witter MP (1987). Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin. Neuroscience 23: 103-120.
18. Holland PC, Bouton ME (1999). Hippocampus and context in classical conditioning. Curr Opin Neurobiol 9: 195-202.
19. Krashes MJ, Koda S, Ye C, Rogan SC, Adams AC, Cusher DS et al (2011). Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J Clin Invest 121: 1424-1428.
20. Morgan JI, Curran T (1991). Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 14: 421-451.
21. Morikawa H, Khodakhah K, Williams JT (2003). Two intracellular pathways mediate metabotropic glutamate receptor-induced Ca2+ mobilization in dopamine neurons. J Neurosci 23: 149-157.
22. Nair SG, Strand NS, Neumaier JF (2013). DREADDing the lateral habenula: a review of methodological approaches for studying lateral habenula function. Brain Res 1511: 93-101.
23. Paxinos G, Watson C (2008). The Rat Brain in Stereotaxic Coordinates, 6th edn. Academic Press: San Diego, CA.
24. Pearce J, Bouton ME (2001). Theories of associative learning in animals. Annu Rev Psych 52: 111-139.
25. Pennartz CM, Groenewegen HJ, Lopes da Silva FH (1994). The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog Neurobiol 42: 719-761.
26. Pickens CL, Airavaara M, Theberge FR, Fanous S, Hope B, Shaham Y (2011). Neurobiology of incubation of cocaine craving. Trends Neurosci 34: 411-420.
27. Rogan SC, Roth BL (2011). Remote control of neuronal signaling. Pharmacol Rev 63: 291-315.
28. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S et al (2002). Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA 99: 11934-11939.
29. Rothermel M, Brunert D, Zabawa C, Diaz-Quesada M, Wachowiak M (2013). Transgene expression in target-defined neuron populations mediated by retrograde infection with adeno-associated viral vectors. J Neurosci 33: 15195-15206.
30. Schoenbaum G, Roesch MR, Stalnaker TA, Takahashi YK (2009). A new perspective on the role of the orbitofrontal cortex in adaptive behaviour. Nat Rev Neurosci 10: 885-892.
31. Schuster CR, Thompson T (1969). Self administration of and behavioral dependence on drugs. Annu Rev Pharmacol 9: 483-502.
32. Sesack SR, Pickel VM (1990). In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res 527: 266-279.
33. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168: 3-20.
34. Tian L, Hires SA, Looger LL (2012). Imaging neuronal activity with genetically encoded calcium indicators. Cold Spring Harb Protoc 2012: 647-656.
35. Tidgewell K, Harding WW, Schmidt M, Holden KG, Murry DJE, Prisinzano T (2004). A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]- salvinorin A. Bioorg Med Chem Lett 14: 5099-5102.
36. Ungless MA, Grace AA (2012). Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci 35: 422-430.
37. Urban DJ, Roth BL (2015). DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. Annu Rev Pharmacol Toxicol 55: 399-417.
38. Vardy E, Robinson JE, Li C, Olsen RHJ, Di Berto JF, Sassano FM et al (2015). A new DREADD facilitates the multiplexed chemogenetic interrogation of behavior. Neuron 86: 936-946.
39. Whitaker LR, Degoulet M, Morikawa H (2013). Social deprivation enhances VTA synaptic plasticity and drug-induced contextual learning. Neuron 77: 335-345.
40. Yang CF, Chiang MC, Gray DC, Prabhakaran M, Alvarado M, Juntti SA et al (2013). Sexually dimorphic neurons in the ventromedial hypothalamus govern mating in both sexes and aggression in males. Cell 153: 896-909.